"Real world" comparison favours angioplasty over thrombolytics
This article was originally published in Clinica
At hospitals with angioplasty facilities, primary angioplasty should be the method of choice for treating acute myocardial infarction. This is the conclusion of the first "real world" comparison of primary angioplasty with intravenous thrombolysis based on data from 9,906 patients enrolled in two multicentre studies in Germany: the Maximal Individual TheRapy in Acute myocardial infarction (MITRA) study and the Myocardial Infarction Registry (MIR). Some 87% of patients received thrombolytics and 13% angioplasty.